Sign in
4/A

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001179110-11-014268

Options or other derivatives

  • Director acquired 455,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

STALDER RUEDI · Director

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2011-09-30 Grant or award : show line 1 in the form Common Stock +155,000 $0.23 2021-09-30 155,000 1,316,787 D
2011-09-30 Grant or award : show line 2 in the form Common Stock Option +300,000 $0.23 2021-09-30 300,000 1,616,787 D
Loading xslF345X03/edgar.xml…